Establishes a medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants test strip program

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 12 Sponsors

No sponsors recorded.

PASSAGE PROBABILITY

3.6% Unlikely

Why this number

Stage base Passed First Chamber — base rate 16%, measured from NY's completed sessions
Momentum +5 74/100 from the pace of recorded action
Time since last action -18 129 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.